Published in Photochem Photobiol on December 15, 2005
Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane. Angiogenesis (2010) 0.97
The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis (2014) 0.94
Advance in photosensitizers and light delivery for photodynamic therapy. Clin Endosc (2013) 0.91
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis (2008) 0.83
Synthesis and biological evaluation of new imidazolium and piperazinium salts of pyropheophorbide-a for photodynamic cancer therapy. Int J Mol Sci (2008) 0.78
Size-dependent photodynamic activity of gold nanoparticles conjugate of water soluble purpurin-18-N-methyl-d-glucamine. Biomed Res Int (2012) 0.77
Syntheses and cellular investigations of di-aspartate and aspartate-lysine chlorin e6 conjugates. Org Biomol Chem (2015) 0.76
The GTPase Ypt7p of Saccharomyces cerevisiae is required on both partner vacuoles for the homotypic fusion step of vacuole inheritance. EMBO J (1995) 3.76
Novel protein kinases associated with calcineurin B-like calcium sensors in Arabidopsis. Plant Cell (1999) 2.02
Phosphatidylinositol 4,5-bisphosphate regulates two steps of homotypic vacuole fusion. Mol Biol Cell (2000) 1.80
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53
Noninvasive determination of the optical properties of two-layered turbid media. Appl Opt (1998) 1.49
Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res (1994) 1.23
Hydration of Escherichia coli lipids. Deuterium T1 relaxation time studies of phosphatidylglycerol, phosphatidylethanolamine and phosphatidylcholine. Biochim Biophys Acta (1983) 1.22
Primary structure and biochemical characterization of yeast GTPase-activating proteins with substrate preference for the transport GTPase Ypt7p. Eur J Biochem (1999) 1.12
Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. Biochem Biophys Res Commun (2005) 1.11
Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proc Natl Acad Sci U S A (1992) 1.11
Clinical determination of tissue optical properties by endoscopic spatially resolved reflectometry. Appl Opt (1996) 1.11
Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer (1999) 1.11
An optical phantom with tissue-like properties in the visible for use in PDT and fluorescence spectroscopy. Phys Med Biol (1997) 1.10
Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med (1997) 1.09
Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol (1998) 1.08
Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer (1991) 1.07
GlycoChip: multiarray for the study of carbohydrate-binding proteins. Lab Chip (2003) 1.04
The full complement of yeast Ypt/Rab-GTPases and their involvement in exo- and endocytic trafficking. Subcell Biochem (2000) 1.03
5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B (2000) 1.03
Study of glycosylation with N-trichloroacetyl-D-glucosamine derivatives in the syntheses of the spacer-armed pentasaccharides sialyl lacto-N-neotetraose and sialyl lacto-N-tetraose, their fragments, and analogues. Carbohydr Res (2001) 1.02
In vivo autofluorescence spectroscopy of human bronchial tissue to optimize the detection and imaging of early cancers. J Biomed Opt (2001) 1.01
Three-dimensional optical phantom and its application in photodynamic therapy. Lasers Surg Med (1997) 0.98
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis (2012) 0.95
In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol (1996) 0.95
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin. Arch Otolaryngol Head Neck Surg (1997) 0.93
Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol (1999) 0.92
Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem Photobiol (1998) 0.91
A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest Ophthalmol Vis Sci (2001) 0.91
Endoscopic tissue characterization by frequency-domain fluorescence lifetime imaging (FD-FLIM). Lasers Med Sci (1997) 0.90
Measurements by fluorescence microscopy of the time-dependent distribution of meso-tetra-hydroxyphenylchlorin in healthy tissues and chemically induced "early" squamous cell carcinoma of the Syrian hamster cheek pouch. J Photochem Photobiol B (1996) 0.89
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. Br J Cancer (1997) 0.89
Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases. Endoscopy (1998) 0.88
Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid. Endoscopy (2003) 0.87
Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study. Br J Cancer (2003) 0.86
[Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options]. J Fr Ophtalmol (2004) 0.85
Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. Br J Cancer (2003) 0.84
Preparative route to glucuronyl donors bearing temporary protecting group at O-3 via 6,3-lactonisation by Bz(2)O or Piv(2)O. Carbohydr Res (2001) 0.84
Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol (2003) 0.83
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis (2008) 0.83
The influence of a steroid hormone and of physical exercise on protein metabolism in rats. Exp Clin Endocrinol (1988) 0.83
Absolute autofluorescence spectra of human healthy, metaplastic, and early cancerous bronchial tissue in vivo. Appl Opt (2001) 0.83
A computer-based method to quantify the classic pattern of choroidal neovascularization in order to monitor photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (1999) 0.83
Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer (1998) 0.83
Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Int J Cancer (1998) 0.82
Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study. Photochem Photobiol (2000) 0.82
Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol (1998) 0.82
Production of the free radicals O2.- and .OH by irradiation of the photosensitizer zinc(II) phthalocyanine. J Photochem Photobiol B (1997) 0.82
Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci (2006) 0.82
Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res (1998) 0.82
Design of an endoscopic optical reference to be used for autofluorescence bronchoscopy with a commercially available diagnostic autofluorescence endoscopy (DAFE) system. Phys Med Biol (2007) 0.82
Comparative 2H- and 31P-NMR study on the properties of palmitoyllysophosphatidylcholine in bilayers with gramicidin, cholesterol and dipalmitoylphosphatidylcholine. Biochim Biophys Acta (1986) 0.81
Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study. J Photochem Photobiol B (2001) 0.81
Infrastructure and clinical practice for the detection and management of trauma-associated haemorrhage and coagulopathy. Eur J Trauma Emerg Surg (2014) 0.81
An alpha-L-fucosidase from Thermus sp. with unusually broad specificity. Glycoconj J (2001) 0.81
Autofluorescence detection of tumors in the human lung--spectroscopical measurements in situ, in an in vivo model and in vitro. Photodiagnosis Photodyn Ther (2008) 0.81
It is all about proteases: from drug delivery to in vivo imaging and photomedicine. Curr Med Chem (2011) 0.81
Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage. Int J Radiat Oncol Biol Phys (1998) 0.80
Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments. Lasers Surg Med (2007) 0.80
Characterization of a T-DNA insertion mutant for the protein import receptor atToc33 from chloroplasts. Mol Genet Genomics (2004) 0.80
Effect of enzyme preparation from the marine mollusk Littorina kurila on fucoidan from the brown alga Fucus distichus. Biochemistry (Mosc) (2005) 0.80
Development of approaches to creation of experimental test system for evaluation of antigenic activity of synthetic oligosaccharide ligands related to fragments of the Streptococcus pneumoniae type 14 capsular polysaccharide. Biochemistry (Mosc) (2013) 0.80
Photodynamic therapy enhances liposomal doxorubicin distribution in tumors during isolated perfusion of rodent lungs. Eur Surg Res (2011) 0.79
Investigation of two-layered turbid media with time-resolved reflectance. Appl Opt (1998) 0.79
The influence of pH and methylene blue on the pathways of glucose utilization and lactate formation in erythrocytes of man. Eur J Biochem (1971) 0.79
Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi. Photochem Photobiol (1999) 0.79
Light dosimetry for photodynamic therapy in the esophagus. Lasers Surg Med (1997) 0.78
Photodynamic therapy induces selective extravasation of macromolecules: Insights using intravital microscopy. J Photochem Photobiol B (2009) 0.78
Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an 'early' squamous cell carcinoma model. Lasers Med Sci (1997) 0.78
Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa. J Photochem Photobiol B (2000) 0.78